SSM Health Care St. Louis DBA SSM St. Clare Health Center

Complete recall history across all FDA and CPSC categories — 14 total recalls

SSM Health Care St. Louis DBA SSM St. Clare Health Center appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (14)

FDA drug safety enforcement actions by SSM Health Care St. Louis DBA SSM St. Clare Health Center

Date Product Reason Class
Feb 29, 2024 FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 m... Lack of Assurance of Sterility: Firm did not perform process validation. Class II
Feb 29, 2024 Phenylephrine HCl, 1000 mcg/10 mL, 10 mL Total Volume per syringe, Intravenou... Lack of Assurance of Sterility: Firm did not perform process validation. Class II
May 9, 2023 HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), ... CGMP Deviations: Discontinuation of the Quality program by manufacturer that ... Class II
Sep 22, 2021 Potassium Chloride 40 mEq in 0.9% Sodium Chloride 270 mL NS, 250 mL bag, Rx O... Lack of Assurance of Sterility Class II
Aug 10, 2017 HYDROmorphone 10 mg in 0.9% Sodium Chloride 50 mL PCA, 50 mL Cartridge, Conce... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Fentanyl 2 mcg/mL and ropivacaine 0.2% in 0.9% Sodium Chloride 150 mL, 150 mL... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Oxytocin 30 units in 0.9% Sodium Chloride 500 mL, 500 mL IV Bag, Concentratio... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mL, 10 mL syringe, Concentr... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Succinylcholine chloride 100 mg in 5 mL syringe, Concentration: 20 mg/mL. Th... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Neostigmine Methylsulfate 5 mg/5 mL, 5 mL Syringe, Concentration: 1 mg/mL. T... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Fentanyl 10 mcg in 0.9% Sodium Chloride 1 mL, 1 mL Vial, Concentration: 10 mc... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCA, 50 mL Cartridge, Concentrati... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Amiodarone 900 mg in dextrose 5% 500 mL, 500 mL bag, Concentration: 1.8 mg/mL... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II
Aug 10, 2017 Norepinephrine 8 mg in dextrose 5% 250 mL, 250mL IV Bag, Concentration: 0.032... Lack of sterility assurance: Microbial growth detected during a routine simul... Class II

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.